HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AI Beauty Solutions Firm Perfect Corp. Going Public Through SPAC; Cosmetics News In Brief

Executive Summary

Perfect Corp. will combine with Hong Kong-based special purpose acquisition company Provident Acquisition Corp. and list on the Nasdaq Stock Exchange in a transaction expected to close in the 2022 third quarter. Sequential Skin launches microbiome in vivo testing to companies assessing product or ingredient impacts on skin flora. More cosmetics news in brief.

You may also be interested in...

Perfect Corp. Highlights Results Of AR-Based Nail Color Sampling At Sally Hansen

Sally Hansen has seen a 300% increase in shades viewed on its website, and a 120% increase in intent to buy, since it introduced Perfect Corp.’s AR-based virtual try-on tool, the beauty tech firm says. French nail-color specialist Manicurist is the latest to partner with Perfect for its Green Flash brand.

Unilever’s Living Proof To Provide First Look At Revieve AI Haircare Advisor

Living Proof will be first out of the gates with the new AI Haircare Advisor from beauty tech firm Revieve. The digital tool is designed to go beyond modeling hair color and tone effects, leveraging consumer input and selfie to match with hair cleansing, conditioning, and styling products.

Investors Bet On UK/Singapore Biotech To Disrupt Personalized Skin Care

Sequential Skin, whose genetic and microbiome home test kit sells for $149, raised $1.65m in a seed round announced on 11 October. The UK/Singapore biotech will use the funds to roll out the kit in the US while extending its B2B offering to skin care, hair care and health care companies for clinical trial and product validation purposes.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts